Milestone Pharmaceuticals announced a poster presentation at the American College of Cardiology annual meeting (ACC25) from March 29th-31st, 2025,...

Creative Medical Technology Holdings (CELZ) announced positive interim data from its Phase 1/2 trial of StemSpine using AlloStem (CELZ-201-DDT),...

Wugen, Inc. has begun its pivotal Phase 2 trial of WU-CART-007, an off-the-shelf CAR-T cell therapy for relapsed or...

Genenta Science secured €20 million (approximately $21.9 million) in financing from ENEA Tech and Biomedical (ETB) to support the...

Pharming Group N.V. has initiated a Phase II clinical trial for leniolisib, targeting common variable immunodeficiency (CVID) patients with...

HUTCHMED announced new data from studies of savolitinib and surufatinib, two compounds it discovered, will be presented at the...

Route 92 Medical announced positive multicenter study results for their Monopoint system, a novel catheter technology designed for neurovascular...

Tenaya Therapeutics will present new clinical data from the MyPEAK-1 Phase 1b/2 trial of TN-201, a gene therapy for...

Conduit Pharmaceuticals announced progress in its preclinical and clinical pipeline, including studies for AZD5658 in lupus, Phase IIa trial...

Protara Therapeutics announced results from THRIVE-1, a study on choline deficiency and liver injury in patients dependent on parenteral...